PERK inhibitors are a class of drugs that target the PERK pathway, which is a key component of the Unfolded Protein Response (UPR). When cells experience stress in the endoplasmic reticulum, PERK is activated to help restore normal function. However, in cancer cells, this pathway is often hijacked to support uncontrolled growth and survival.
